Market overview
The global nutraceutical market is worth USD 516 bn in 2026 and is forecast to reach USD 1.1 tn by 2036, growing at a 7.5% CAGR. United States is the largest country market and Dietary supplements is the largest by product segment.
| Scope | Foods, drinks and supplements sold for health benefits beyond basic nutrition: vitamins, minerals, botanicals, probiotics, functional foods and functional beverages. |
|---|---|
| Industry | Healthcare |
| Value 2025 | USD 480 bn |
| Value 2026 | USD 516 bn |
| Value 2036 | USD 1.1 tn |
| CAGR 2026-2036 | 7.5% |
| Volume 2026 | 29,655 thousand tonnes |
| Volume 2036 | 52,665 thousand tonnes |
| Average price 2026 | USD 17,400 per tonne |
| Report price | Starts from USD 1,999 |
| Published | November 2026 |
Request a free sample of this report
Nutraceutical market size and forecast, 2026-2036
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Year | Market value |
|---|---|
| 2026 | USD 516 bn |
| 2027 | USD 555 bn |
| 2028 | USD 596 bn |
| 2029 | USD 641 bn |
| 2030 | USD 689 bn |
| 2031 | USD 741 bn |
| 2032 | USD 796 bn |
| 2033 | USD 856 bn |
| 2034 | USD 920 bn |
| 2035 | USD 989 bn |
| 2036 | USD 1.1 tn |
Nutraceutical market segmentation
By product
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Dietary supplements | 38.0% | 36.1% | USD 196 bn | 7.0% |
| Functional foods | 36.0% | 34.2% | USD 186 bn | 7.0% |
| Functional beverages | 26.0% | 29.7% | USD 134 bn | 8.9% |
By ingredient
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Vitamins and minerals | 28.0% | 23.8% | USD 144 bn | 5.8% |
| Probiotics and prebiotics | 16.0% | 19.7% | USD 82.6 bn | 9.8% |
| Botanicals and herbal | 18.0% | 17.6% | USD 92.9 bn | 7.3% |
| Proteins and amino acids | 18.0% | 19.3% | USD 92.9 bn | 8.3% |
| Omega-3 and others | 20.0% | 19.6% | USD 103 bn | 7.3% |
By health function
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Immunity | 22.0% | 22.0% | USD 114 bn | 7.5% |
| Digestive health | 18.0% | 19.0% | USD 92.9 bn | 8.1% |
| Cardiovascular health | 14.0% | 13.0% | USD 72.2 bn | 6.7% |
| Bone and joint | 16.0% | 15.0% | USD 82.6 bn | 6.8% |
| Weight and energy | 18.0% | 18.0% | USD 92.9 bn | 7.5% |
| Cognitive and others | 12.0% | 13.0% | USD 61.9 bn | 8.4% |
By form
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Tablets and capsules | 42.0% | 38.0% | USD 217 bn | 6.4% |
| Powders | 22.0% | 22.0% | USD 114 bn | 7.5% |
| Gummies | 14.0% | 18.0% | USD 72.2 bn | 10.2% |
| Liquids and drinks | 22.0% | 22.0% | USD 114 bn | 7.5% |
By channel
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Pharmacy and drug stores | 30.0% | 26.0% | USD 155 bn | 6.0% |
| Supermarkets and health stores | 28.0% | 25.0% | USD 144 bn | 6.3% |
| Online | 26.0% | 34.0% | USD 134 bn | 10.4% |
| Direct selling | 16.0% | 15.0% | USD 82.6 bn | 6.8% |
Top 25 countries for nutraceutical by revenue
Countries are ranked by revenue earned from sales in the country, not by where the product is made. The ten largest hold 77.0% of 2026 revenue and the 25 countries below together hold 94.5%.
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| # | Country | Value 2026 | Share 2026 | Value 2036 | CAGR 2026-36 |
|---|---|---|---|---|---|
| 1 | United States | USD 144 bn | 28.0% | USD 278 bn | 6.8% |
| 2 | China | USD 87.7 bn | 17.0% | USD 213 bn | 9.3% |
| 3 | Japan | USD 41.3 bn | 8.0% | USD 69.1 bn | 5.3% |
| 4 | Germany | USD 25.8 bn | 5.0% | USD 47.9 bn | 6.4% |
| 5 | India | USD 20.6 bn | 4.0% | USD 62.7 bn | 11.8% |
| 6 | United Kingdom | USD 18.1 bn | 3.5% | USD 33.0 bn | 6.2% |
| 7 | France | USD 15.5 bn | 3.0% | USD 26.6 bn | 5.6% |
| 8 | Brazil | USD 15.5 bn | 3.0% | USD 36.2 bn | 8.8% |
| 9 | South Korea | USD 15.5 bn | 3.0% | USD 33.0 bn | 7.8% |
| 10 | Australia | USD 12.9 bn | 2.5% | USD 25.5 bn | 7.1% |
| 11 | Italy | USD 12.5 bn | 2.4% | USD 27.1 bn | 8.1% |
| 12 | Spain | USD 11.1 bn | 2.2% | USD 22.1 bn | 7.1% |
| 13 | Mexico | USD 9.4 bn | 1.8% | USD 18.7 bn | 7.1% |
| 14 | Russia | USD 8.3 bn | 1.6% | USD 16.5 bn | 7.2% |
| 15 | Indonesia | USD 7.9 bn | 1.5% | USD 15.6 bn | 7.1% |
| 16 | Thailand | USD 6.7 bn | 1.3% | USD 13.3 bn | 7.2% |
| 17 | Netherlands | USD 6.1 bn | 1.2% | USD 12.1 bn | 7.1% |
| 18 | Turkey | USD 5.2 bn | 1.0% | USD 10.3 bn | 7.2% |
| 19 | Taiwan | USD 4.7 bn | 0.9% | USD 9.4 bn | 7.1% |
| 20 | Poland | USD 4.0 bn | 0.8% | USD 8.0 bn | 7.1% |
| 21 | Switzerland | USD 3.7 bn | 0.7% | USD 7.2 bn | 7.0% |
| 22 | Malaysia | USD 3.4 bn | 0.7% | USD 6.6 bn | 7.0% |
| 23 | Philippines | USD 2.9 bn | 0.6% | USD 5.8 bn | 7.1% |
| 24 | Vietnam | USD 2.4 bn | 0.5% | USD 4.8 bn | 7.3% |
| 25 | Saudi Arabia | USD 2.0 bn | 0.4% | USD 4.0 bn | 7.2% |
| Rest of world | USD 28.5 bn | 5.5% | USD 57.6 bn | 7.3% |
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
Competitive landscape
Group 1: Global leaders
- Nestle
- Danone
- Abbott
- Herbalife
- Amway
- PepsiCo
- Otsuka Holdings
Group 2: Regional and specialist players
- Kellanova
- Glanbia
- Haleon
- Bayer Consumer Health
- Suntory
- Yakult
- Pharmavite
- DSM-Firmenich
- Archer Daniels Midland
- Kemin Industries
Group 3: Emerging and niche players
- By-Health
- Blackmores
- Nature's Sunshine
- Himalaya Wellness
- Nordic Naturals
- Swisse Wellness
- Gaia Herbs
- Ancient Nutrition
Research methodology
Every figure on this page comes from the research framework that we apply to all of the markets we cover. The 2025 base for the nutraceutical market is built from the volume sold and the price that buyers pay, and is cross-checked against the size of the wider industry the market belongs to. Where a market can be sized in more than one way, the routes are compared before a figure is set.
The forecast runs year by year from the 2025 base to 2036. Growth in each year reflects demand from the industries that buy the product, adoption of new technology, pricing, regulation and replacement cycles. Volume and price are modelled together, so revenue in each year equals volume multiplied by average price. The 2026 to 2036 compound annual growth rate of 7.5% is calculated from the resulting values.
The market is divided by product, by ingredient, by health function, by form, by channel. The 25 largest countries are ranked by revenue earned from sales to buyers in each country, not by where the product is made. Segment values and country values add up to the market total in every year, and every report is checked for consistency before it is published.
Companies are placed in three groups: global leaders, regional and specialist players, and emerging and niche players. The groups describe how companies compete in the market. They are not a ranking and they are not market shares.
Our analysts also carry out primary research. Customized reports add interviews with key opinion leaders, such as senior executives, technical specialists and buyers, to test the assumptions behind the numbers for the question being asked.
Frequently asked questions
How big is the nutraceutical market?
The global nutraceutical market is estimated at USD 480 bn in 2025 and USD 516 bn in 2026.
How fast will the nutraceutical market grow?
It is forecast to reach USD 1.1 tn by 2036, a compound annual growth rate of 7.5% from 2026, an increase of USD 547 bn.
Which country is the largest market for nutraceutical?
United States is the largest market by revenue at USD 144 bn in 2026, 28.0% of the global total. The three largest countries together hold 53.0%.
Which country is growing fastest?
Among the ten largest markets, India is growing fastest at 11.8% a year from 2026 to 2036.
Which nutraceutical segment is largest?
In the by product split, Dietary supplements is the largest segment with 38.0% of 2026 revenue.
Who are the leading nutraceutical companies?
Global leaders include Nestle, Danone, Abbott, Herbalife.
Need the full report?
Request a sample to see the structure, tables and country detail.
Request a free sampleRelated markets in Healthcare
- Mental Health ServicesUSD 511 bn · 6.0% CAGR
- Specialty PharmacyUSD 523 bn · 8.5% CAGR
- Hospital PharmacyUSD 509 bn · 6.3% CAGR
- BiologicsUSD 508 bn · 8.0% CAGR
- Generic DrugsUSD 462 bn · 5.0% CAGR
- TabletUSD 580 bn · 5.5% CAGR
- Sterile InjectableUSD 454 bn · 8.5% CAGR
- Home HealthcareUSD 410 bn · 8.0% CAGR